GWM
QLTY icon

Geneos Wealth Management’s GMO US Quality ETF QLTY Stock Holding History

Geneos Wealth Management’s Portfolio QLTY Stock Details QLTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Buy
744
+1
+0.1% +$40 ﹤0.01% 1651
2026
Q1 		$26.9K Buy
743
+2
+0.3% +$77 ﹤0.01% 1664
2025
Q4 		$28.5K Buy
741
+1
+0.1% +$38 ﹤0.01% 1604
2025
Q3 		$26.8K Buy
740
+2
+0.3% +$70 ﹤0.01% 1613
2025
Q2 		$25.3K Buy
738
+1
+0.1% +$32 ﹤0.01% 1915
2025
Q1 		$23K Buy
737
+2
+0.3% +$65 ﹤0.01% 1884
2024
Q4 		$23.5K Buy
+735
New +$23.9K ﹤0.01% 1655

Other funds holding QLTY

AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TODC
Trustees of Dartmouth College Hanover, New Hampshire $335M AUM 18.36% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $1.07B AUM 26.49% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geneos Wealth Management's QLTY Position: Q2 2026 in Review

Geneos Wealth Management increased its GMO US Quality ETF (QLTY) stake by 0.13% in Q2 2026, buying an estimated $40 and bringing the position to 744 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Geneos Wealth Management first reported a position in QLTY in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Geneos Wealth Management held 744 shares of GMO US Quality ETF worth $31K as of Q2 2026.
  • Geneos Wealth Management bought 1 GMO US Quality ETF share in Q2 2026, an estimated $40.
  • GMO US Quality ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1651 holding.
  • Geneos Wealth Management first reported a position in GMO US Quality ETF in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.